Literature DB >> 16206063

Mononucleosis in the laboratory.

Richard F Ambinder, Lan Lin.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16206063     DOI： 10.1086/491746

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

1.  Exposure to Epstein Barr virus and cognitive functioning in individuals with schizophrenia.

Authors:  Faith Dickerson; Emily Katsafanas; Andrea Origoni; Amalia Squire; Sunil Khushalani; Theresa Newman; Kelly Rowe; Cassie Stallings; Christina L G Savage; Kevin Sweeney; Tanya T Nguyen; Alan Breier; Donald Goff; Glen Ford; Lorraine Jones-Brando; Robert Yolken
Journal:  Schizophr Res       Date:  2021-01-12       Impact factor: 4.939

Review 2.  Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2012-02-12

Review 3.  Progress and problems in understanding and managing primary Epstein-Barr virus infections.

Authors:  Oludare A Odumade; Kristin A Hogquist; Henry H Balfour
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Atypical immune response to Epstein-Barr virus in major depressive disorder.

Authors:  Lorraine Jones-Brando; Faith Dickerson; Glen Ford; Cassie Stallings; Andrea Origoni; Emily Katsafanas; Kevin Sweeney; Amalia Squire; Sunil Khushalani; Robert Yolken
Journal:  J Affect Disord       Date:  2019-11-30       Impact factor: 4.839

5.  Diagnostic Performance and Comparative Evaluation of the Architect, Liaison, and Platelia Epstein-Barr Virus Antibody Assays.

Authors:  Younhee Park; Borae G Park; Jihye Ha; Hyon Suk Kim
Journal:  Ann Lab Med       Date:  2018-09       Impact factor: 3.464

6.  Schizophrenia is Associated With an Aberrant Immune Response to Epstein-Barr Virus.

Authors:  Faith Dickerson; Lorraine Jones-Brando; Glen Ford; Giulio Genovese; Cassie Stallings; Andrea Origoni; Colm O'Dushlaine; Emily Katsafanas; Kevin Sweeney; Sunil Khushalani; Robert Yolken
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.